Avanos Medical Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio25.14263.28
Forward P/E10.1015.6515.8923.1648.55
P/S Ratio1.001.551.862.833.05
P/B Ratio0.830.850.981.301.74
Price/Tangible Book2.645.214.285.067.36
Price/FCF8.2971.6017.7325.02
Price/OCF6.8232.2613.9719.00
PEG Ratio4.392.341.171.303.49
Enterprise Value Ratios
EV/Revenue1.161.852.133.013.25
EV/EBITDA8.8614.4918.9941.6749.09
EV/EBIT17.8629.3641.04430.89527.69
EV/FCF9.6585.2720.3526.65
Profitability & Returns
Return on Equity (ROE)-0.37%-0.01%0.02%-0.02%-0.02%
Return on Assets (ROA)0.02%0.02%0.01%0.00%0.00%
Return on Invested Capital (ROIC)0.04%0.03%0.02%0.00%0.00%
Return on Capital Employed (ROCE)0.04%0.03%0.02%0.00%0.00%
Leverage & Solvency Ratios
Debt/Equity0.200.170.210.150.20
Debt/EBITDA1.642.083.043.283.46
Debt/FCF2.0514.323.872.83
Liquidity Ratios
Current Ratio2.372.083.273.072.81
Quick Ratio1.450.981.551.791.68
Efficiency Ratios
Asset Turnover0.480.390.400.360.41
Inventory Turnover2.031.991.991.752.19
Yield & Distribution Ratios
Earnings Yield-0.57%-0.06%0.04%0.00%-0.01%
FCF Yield0.12%0.01%0.06%0.04%-0.01%
Buyback Yield0.01%0.01%0.03%-0.02%0.00%